Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transurethral Modified En Bloc Resection For Large Bladder Tumours.

NCT: NCT04081246 · COMPLETED

NCT IDNCT04081246
StatusCOMPLETED
Start Date2020-09-07
Completion2024-03-15
SponsorChinese University of Hong Kong (OTHER)
First posted
Last updated

Brief Summary

Modified en bloc resection is a hybrid technique involving piecemeal resection of the exophytic part of the bladder tumour, followed by en bloc resection of the tumour base. In this study, we shall investigate the efficacy of modified en bloc resection for patients with bladder tumours of ≥3cm in size.

Frequently Asked Questions

What is Transurethral Modified En Bloc Resection For Large Bladder Tumours.?

Transurethral Modified En Bloc Resection For Large Bladder Tumours. is a clinical trial registered under NCT04081246. Current status: COMPLETED.

What is the status of NCT04081246?

The current status of NCT04081246 (Transurethral Modified En Bloc Resection For Large Bladder Tumours.) is: COMPLETED.

When did Transurethral Modified En Bloc Resection For Large Bladder Tumours. start?

Transurethral Modified En Bloc Resection For Large Bladder Tumours. started on 2020-09-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑